L03AX13 • glatiramer acetate • Antineoplastic and immunomodulating agents | Immunostimulants | Other immunostimulants
Glatiramer acetate is a medication used for the treatment of relapsing-remitting multiple sclerosis. It works by modulating the immune response, reducing inflammation, and preventing damage to myelin, the protective layer of nerves.
The medication is administered via subcutaneous injection, usually daily or several times a week, depending on the dosage. Glatiramer acetate has shown efficacy in reducing relapse frequency and slowing disease progression.
Common side effects include injection site reactions, flushing, and palpitations. It is important for patients to be properly trained in injection administration and monitored for potential side effects.
Glatiramer acetate is a well-established therapeutic option for patients with multiple sclerosis, helping to improve their quality of life.
Substance: glatiramer acetate
Date of last drug list: 01-07-2013
Commercial code: W44043002
Concentration: 20mg
Pharmaceutical form: lyophilizate + solvent for injection
Quantity: 28
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).